Mittwoch, 20.10.2021 17:53 von GlobeNewswire | Aufrufe: 339

Global Bioenergies makes breakthrough on the road toward biojet fuel

Wirtschaftsnachrichten (Symbolbild). pixabay.com

 Global Bioenergies makes breakthrough on the road toward biojet fuel

Evry, 20 October 2021: Global Bioenergies has made major advances in its process for converting plant-based feedstocks into isobutene. The resulting improved performance will speed up penetration of the cosmetics market over the next few years and allows to target production costs that would make this process the world leader for converting industrial sugars into biojet fuel.

Since 2019, Global Bioenergies has focused on cosmetics applications for its process, isobutene derivatives being an important input for these markets, and recently launched its own make-up brand, LAST®, the first to combine longwear performance with low transfer in an over 90% natural product.

It is now building a production unit at Pomacle site near Reims, so the industry's big names can start buying into this innovation, increasing the naturalness of their make-up formulations. The unit will come onstream in the first quarter 2022 with annual capacity of around 100 tonnes.

Kurse

  
5,12
+2,91%
GLOBAL BIOENERGIES Chart

Marc Delcourt, co-founder and CEO of Global Bioenergies, explained: “Many solutions, such as electric or hydrogen-powered planes, have been put forward as ways to cut the externalities of air travel, i.e. the environmental destruction caused by flights’ CO2 emissions. But the consensus has identified biojet fuel as the best solution for the next few decades. Biojet fuel has a modest additional cost - which is falling anyway as oil prices spiral - and will be usable in existing planes without engine modifications.

After an initial phase working with plant-oil-based biojet fuel that has now reached certain limits, global priorities are turning toward more productive processes based on industrial sugars that can reduce CO2 by a factor of 3-5. Our exclusive “deeptech” technology is addressing this environment. Our strategy follows a four-step roadmap, focusing short-term on the cosmetics market, which has lower volumes but higher margins than energy. Our recent technical progress has confirmed our conviction that our process can be scaled up in future to serve the big energy markets.

Reducing the CO2 emissions of aircraft is one of the 10 objectives of the France 2030 plan. The multiple applications of our process (cosmetics, air transport, plastics, rubbers, specialty and commodity chemicals) mean we can decarbonise our industries on a grand scale. Our factories will rely on farm inputs and be rooted in the regions. Rolling out our process will thus help strengthen France's industrial and energy sovereignty.

Finally, I would like to thank our 10,000 shareholders for the vital trust they have placed in the Company. Backed by the determination and commitment of the Group’s employees, they have brought us within touching distance of becoming a key player in the environmental transition and preserving the planet as a place where future generations can live in harmony.”

About GLOBAL BIOENERGIES

Global Bioenergies has developed a process to convert plant-derived resources into a key family of ingredients used in the cosmetics industry. The process was first developed in a laboratory, where the Company is further enhancing performance. It now operates as a pilot and a demo plant, with the capacity to start breaking into the market, initially through the Company's longwear home make-up brand, launched in 2021. The Company is gradually expanding its production capacities and is looking to improve the environmental footprint of not only the cosmetics industry but also that of other areas such as transportation and materials. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 – ALGBE)

Receive information about Global Bioenergies directly by subscribing to our news feed on www.global-bioenergies.com

Follow us on Twitter: @GlobalBioenergi

Contact

GLOBAL BIOENERGIES

Pauline Bayec
Head of Investor Relations & Corporate Communication
Tel.: +33 (0)1 64 98 20 50
invest@global-bioenergies.com

Attachment


Werbung
Mehr Nachrichten zur BioNTech SE ADR Aktie kostenlos abonnieren
E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptieren Sie die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.

Andere Nutzer interessierte auch dieser Artikel: